Long‐Term Impact of 1‐mm Versus 3‐mm Definitive Abutments on Marginal Bone Loss and Peri‐Implant Disease: A 7‐Year Randomised Clinical Trial

To evaluate bone level changes in implants with 1-mm- or 3-mm-high abutments over a 7-year period and to investigate the role of abutment height upon peri-implant status. Two-piece implants were placed 1.5 mm subcrestally with either 1-mm (control) or 3-mm (test) high definitive abutments. Marginal...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical periodontology
Main Authors Muñoz, Marta, Pardo, Germán, Vilarrasa, Javi, Babiano, Álvaro, Ruíz‐Magaz, Vanessa, Nart, José
Format Journal Article
LanguageEnglish
Published United States 18.08.2025
Subjects
Online AccessGet full text
ISSN0303-6979
1600-051X
1600-051X
DOI10.1111/jcpe.70009

Cover

Loading…
More Information
Summary:To evaluate bone level changes in implants with 1-mm- or 3-mm-high abutments over a 7-year period and to investigate the role of abutment height upon peri-implant status. Two-piece implants were placed 1.5 mm subcrestally with either 1-mm (control) or 3-mm (test) high definitive abutments. Marginal bone level change from the first to seventh year was the primary outcome. Peri-implant status and other patient and peri-implant clinical variables (smoking, peri-implant maintenance therapy compliance, interproximal hygiene, vertical soft tissue thickness and keratinised mucosa width) were also assessed. After 7 years, 37 subjects (63 implants) were analysed: 17 subjects with 32 implants in the 1-mm abutment group, and 20 subjects with 31 implants in the 3-mm abutment group. Significant differences in marginal bone level changes were observed at 7 years. The 3-mm abutment group showed smaller changes compared to the 1-mm abutment group at mesial sites (-0.27 ± 1.32 mm vs. -0.42 ± 0.50 mm, respectively) and distal sites (-0.33 ± 1.39 mm vs. -0.35 ± 0.38 mm), with both differences being statistically significant (p < 0.001). In the control group, 18 implants (54.6%) presented peri-implant mucositis and 6 implants (18.2%) showed peri-implantitis. In the test group, 23 implants (74.2%) presented peri-implant mucositis and 1 implant (3.2%) showed peri-implantitis. No statistically significant differences were found (p = 0.158). Subcrestally inserted implants with 3-mm definitive abutments experienced minimal bone loss over long-term follow-up compared to 1-mm abutments. However, since the differences were not statistically significant, no conclusions could be drawn on the protective effect against peri-implantitis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0303-6979
1600-051X
1600-051X
DOI:10.1111/jcpe.70009